BeiGene
ONC
#699
Rank
A$44.07 B
Marketcap
$388.40
Share price
-3.11%
Change (1 day)
75.09%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -$9.53

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -$9.76. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-$9.76
2022-$30.5228.21%
2021-$23.80-19.96%
2020-$29.7420.81%
2019-$24.6231.52%
2018-$18.72417.57%
2017-$3.62-37.16%
2016-$5.75158.95%
2015-$2.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.56-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.42-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA